Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Recs

0
Player Avatar MJKpayday (99.69) Submitted: 6/10/2009 9:12:59 AM : Underperform Start Price: $12.80 VNDA Score: +107.15

Plucked this from "UltraLong" who currently has a 98% accuracy rate. Holy Sh#% 98%?!?

This pharmaceutical has big spike on good news, but it's badly run and overvalued.

Featured Broker Partners


Advertisement